Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Incao

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Genesis (New York, N.Y. : 2000)|June 21, 2001
In utero complementation of a neural crest-derived melanocyte defect using cell directed gene transferK J Dunn, A Incao, D Watkins-Chow, et al.
Pigment Cell & Melanoma Research|October 24, 2023
The MFSD12 p.Tyr182His common variant is sufficient to alter mouse agouti coat colorDawn E Watkins-Chow, Arturo A Incao, Cecelia Rivas, et al.
Plos One|March 11, 2026
Comparison of neonatal systemic and intracerebroventricular AAV9 gene therapy delivery demonstrating improved behavioral and phenotypic outcomes in a mouse model of Niemann-Pick disease, type C1Benjamin E Epstein, Gabrielle M Soden, Arturo A Incao, et al.
Human Molecular Genetics|November 1, 2016
Systemic AAV9 gene therapy improves the lifespan of mice with Niemann-Pick disease, type C1Randy J Chandler, Ian M Williams, Alana L Gibson, et al.
Biorxiv : the Preprint Server for Biology|June 19, 2024
Optimization of systemic AAV9 gene therapy in Niemann-Pick disease type C1 miceAvani V Mylvara, Alana L Gibson, Tansy Gu, et al.
Life Science Alliance|March 30, 2026
Optimization of systemic AAV9 gene therapy in Niemann-Pick disease, type C1 miceAvani V Mylvara, Alana L Gibson, Tansy Gu, et al.
Human Molecular Genetics|July 23, 2021
Transcriptome of HPβCD-treated Niemann-Pick disease type C1 cells highlights GPNMB as a biomarker for therapeuticsJorge L Rodriguez-Gil, Laura L Baxter, Dawn E Watkins-Chow, et al.
Life Science Alliance|August 19, 2021
Improved systemic AAV gene therapy with a neurotrophic capsid in Niemann-Pick disease type C1 miceCristin D Davidson, Alana L Gibson, Tansy Gu, et al.
Disease Models & Mechanisms|January 31, 2020
Genetic background modifies phenotypic severity and longevity in a mouse model of Niemann-Pick disease type C1Jorge L Rodriguez-Gil, Dawn E Watkins-Chow, Laura L Baxter, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Genesis (New York, N.Y. : 2000)|June 21, 2001
In utero complementation of a neural crest-derived melanocyte defect using cell directed gene transferK J Dunn, A Incao, D Watkins-Chow, et al.
Pigment Cell & Melanoma Research|October 24, 2023
The MFSD12 p.Tyr182His common variant is sufficient to alter mouse agouti coat colorDawn E Watkins-Chow, Arturo A Incao, Cecelia Rivas, et al.
Plos One|March 11, 2026
Comparison of neonatal systemic and intracerebroventricular AAV9 gene therapy delivery demonstrating improved behavioral and phenotypic outcomes in a mouse model of Niemann-Pick disease, type C1Benjamin E Epstein, Gabrielle M Soden, Arturo A Incao, et al.
Human Molecular Genetics|November 1, 2016
Systemic AAV9 gene therapy improves the lifespan of mice with Niemann-Pick disease, type C1Randy J Chandler, Ian M Williams, Alana L Gibson, et al.
Biorxiv : the Preprint Server for Biology|June 19, 2024
Optimization of systemic AAV9 gene therapy in Niemann-Pick disease type C1 miceAvani V Mylvara, Alana L Gibson, Tansy Gu, et al.
Life Science Alliance|March 30, 2026
Optimization of systemic AAV9 gene therapy in Niemann-Pick disease, type C1 miceAvani V Mylvara, Alana L Gibson, Tansy Gu, et al.
Human Molecular Genetics|July 23, 2021
Transcriptome of HPβCD-treated Niemann-Pick disease type C1 cells highlights GPNMB as a biomarker for therapeuticsJorge L Rodriguez-Gil, Laura L Baxter, Dawn E Watkins-Chow, et al.
Life Science Alliance|August 19, 2021
Improved systemic AAV gene therapy with a neurotrophic capsid in Niemann-Pick disease type C1 miceCristin D Davidson, Alana L Gibson, Tansy Gu, et al.
Disease Models & Mechanisms|January 31, 2020
Genetic background modifies phenotypic severity and longevity in a mouse model of Niemann-Pick disease type C1Jorge L Rodriguez-Gil, Dawn E Watkins-Chow, Laura L Baxter, et al.
Pageof 1